ResMed

RMD • NYSE •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $1,196,980 $1,162,801 $963,037 $1,122,057
Gross Profit 681,577 646,934 600,060 617,386
EBITDA 429,226 456,920 288,997 333,761
EBIT 374,584 403,550 235,555 278,561
Net Income 300,492 208,800 219,422 229,664
Net Change In Cash 1,196,980 1,162,801 963,037 1,122,057
Free Cash Flow 378,922 248,274 245,417 198,703
Cash 237,910 210,247 209,100 227,891
Basic Shares 147,450 147,545 147,486 147,554

Annual Financials

Values in thousands 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Revenue $4,222,993 $3,578,127 $3,196,825 $2,957,013
Gross Profit 2,355,662 2,024,311 1,839,100 1,717,786
EBITDA 1,339,536 1,194,127 1,112,542 989,832
EBIT 1,141,974 1,000,286 903,678 809,659
Net Income 897,556 779,437 474,505 621,674
Net Change In Cash 4,222,993 3,578,127 3,196,825 2,957,013
Cost of Revenue 316,028
Free Cash Flow 559,299 195,111 619,892 696,317
Cash 227,891 273,710 295,278 463,156
Basic Shares 147,455 147,043 146,451 145,652

Earnings Calls

Quarter EPS
2024-03-31 $2.13
2023-12-31 $1.88
2023-09-30 $1.64
2023-06-30 $1.60